Free Trial
CVE:ZOM

Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM) Stock Price, News & Analysis

Zomedica Pharmaceuticals Corp. (ZOM.V) logo
C$0.28 -0.02 (-6.56%)
As of 02/5/2020

About Zomedica Pharmaceuticals Corp. (ZOM.V) Stock (CVE:ZOM)

Key Stats

Today's Range
C$0.29
C$0.29
50-Day Range
C$0.29
C$0.29
52-Week Range
C$0.29
C$1.50
Volume
4,800 shs
Average Volume
2,858 shs
Market Capitalization
C$36.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zomedica Pharmaceuticals Corp. (ZOM.V) and its competitors with MarketBeat's FREE daily newsletter.

ZOM Stock News Headlines

Zomedica Corp. trading halted, news pending
Zomedica Pharmaceuticals (ZOM) Receives a Buy from Noble Financial
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
Phio Pharmaceuticals Corp.
Zomedica Corp. (ZOM) Q2 2024 Earnings Call Transcript
Zomedica Corp Ordinary Shares ZOM
Zomedica Stock (AMEX:ZOM), Dividends
See More Headlines

ZOM Stock Analysis - Frequently Asked Questions

Zomedica Pharmaceuticals Corp. (ZOM.V)'s stock was trading at C$0.29 on January 1st, 2025. Since then, ZOM stock has increased by 0.0% and is now trading at C$0.29.

Shares of ZOM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zomedica Pharmaceuticals Corp. (ZOM.V) investors own include Ocugen (OCGN), T2 Biosystems (TTOO), Meta Platforms (META), Bionano Genomics (BNGO), Onconova Therapeutics (ONTX), Biocept (BIOC) and Ford Motor (F).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:ZOM
CIK
N/A
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
4.91
Current Ratio
15.31
Quick Ratio
15.25

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.05 per share
Price / Cash Flow
5.38
Book Value
C$0.05 per share
Price / Book
5.82

Miscellaneous

Outstanding Shares
128,872,000
Free Float
N/A
Market Cap
C$36.73 million
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (CVE:ZOM) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners